TRVI
NASDAQ · Pharmaceuticals
Trevi Therapeutics Inc
$18.51
+0.01 (+0.05%)
Open$19.26
Previous Close$18.50
Day High$19.26
Day Low$17.90
52W High$20.22
52W Low$6.55
Volume—
Avg Volume1.66M
Market Cap2.61B
P/E Ratio—
EPS$-0.32
SectorPharmaceuticals
Analyst Ratings
Strong Buy
18 analysts
Price Target
+18.5% upside
Current
$18.51
$18.51
Target
$21.93
$21.93
$18.04
$21.93 avg
$33.12
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 772.80M | 683.27M | 746.33M |
| Net Income | 98.54M | 104.02M | 99.75M |
| Profit Margin | 12.8% | 15.2% | 13.4% |
| EBITDA | 196.14M | 177.32M | 185.79M |
| Free Cash Flow | 50.24M | 55.58M | 60.41M |
| Rev Growth | +0.7% | +7.7% | +15.7% |
| Debt/Equity | 0.64 | 0.66 | 0.70 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |